Japanese encephalitis

A Single Dose of Vero Cell-Derived Japanese Encephalitis (JE) Vaccine (Ixiaro) Effectively Boosts Immunity in Travelers Primed With Mouse Brain-Derived JE Vaccines

(2012) E. O. Erra et al.   CLINICAL INFECTIOUS DISEASES

Clinical development of IMOJEV®—a recombinant Japanese encephalitis chimeric vaccine (JE-CV)

(2012) Mohan Babu Appaiahgari et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Novel approaches to flavivirus drug discovery

(2012) Carolyn Botting et al.   Expert Opinion on Drug Discovery

Biological and genetic properties of SA14-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans

(2012) Byung-Hak Song et al.   JOURNAL OF MICROBIOLOGY

Suppressive Effects on the Immune Response and Protective Immunity to a JEV DNA Vaccine by Co-administration of a GM-CSF-Expressing Plasmid in Mice

(2012) Hui Chen et al.   PLoS One

Safety and immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (Inactivated) (JEBIK®V) in children

(2012) Kenji Okada et al.   VACCINE

Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated)

(2012) Akiko Kikukawa et al.   VACCINE

Immune evasion strategies of flaviviruses

(2012) Jing Ye et al.   VACCINE

Multiple linear epitopes (B-cell, CTL and Th) of JEV expressed in recombinant MVA as multiple epitope vaccine induces a protective immune response

(2012) Fengjuan Wang et al.   Virology Journal

Innate Immunity Evasion by Dengue Virus

(2012) Juliet Morrison et al.   Viruses-Basel

Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12–18 months: Randomized, controlled phase 3 immunogenicity and safety trial

(2012) Emmanuel Feroldi et al.   Human Vaccines & Immunotherapeutics

Partially Neutralizing Potency against Emerging Genotype I Virus among Children Received Formalin-Inactivated Japanese Encephalitis Virus Vaccine

(2012) Yi-Chin Fan et al.   PLoS Neglected Tropical Diseases

New Japanese encephalitis vaccines: alternatives to production in mouse brain

(2011) Scott B Halstead et al.   Expert Review of Vaccines

Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine

(2011) Peter E Nasveld et al.   Human vaccines & immunotherapeutics

Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine

(2011) Peter E. Nasveld et al.   Human vaccines & immunotherapeutics

Molecular phylogenetic and evolutionary analyses of Muar strain of Japanese encephalitis virus reveal it is the missing fifth genotype

(2011) Manal A.F. Mohammed et al.   INFECTION GENETICS AND EVOLUTION

Emergence of Genotype I of Japanese Encephalitis Virus as the Dominant Genotype in Asia

(2011) X.-L. Pan et al.   JOURNAL OF VIROLOGY

Pivotal Role of Antibody and Subsidiary Contribution of CD8+ T Cells to Recovery from Infection in a Murine Model of Japanese Encephalitis

(2011) M. Larena et al.   JOURNAL OF VIROLOGY

Japanese encephalitis virus: from genome to infectome

(2011) Salini Krishnan Unni et al.   MICROBES AND INFECTION

Isolation and Genetic Characteristics of Human Genotype 1 Japanese Encephalitis Virus, China, 2009

(2011) Jiu-Song Zhang et al.   PLoS One

Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China

(2011) Xinyu Liu et al.   VACCINE

Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51

(2011) Susanne Eder et al.   VACCINE

Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO®

(2011) Elisabeth Schuller et al.   VACCINE

Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO®) induced neutralizing antibody titers

(2011) Yvonne Van Gessel et al.   VACCINE

Antibody-mediated neutralization of flaviviruses: A reductionist view

(2011) Kimberly A. Dowd et al.   VIROLOGY

Emergence of Japanese encephalitis virus genotype V in the Republic of Korea

(2011) Ratree Takhampunya et al.   Virology Journal

Genotype V Japanese Encephalitis Virus Is Emerging

(2011) Ming-Hua Li et al.   PLoS Neglected Tropical Diseases

Anterior horn cells are also involved in Japanese encephalitis

(2010) U. K. Misra et al.   ACTA NEUROLOGICA SCANDINAVICA

Japanese Encephalitis in Travelers from Non-Endemic Countries, 1973–2008

(2010) Susan L. Hills et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Strategies for development of dengue virus inhibitors

(2010) Christian G. Noble et al.   ANTIVIRAL RESEARCH

Viral Reorganization of the Secretory Pathway Generates Distinct Organelles for RNA Replication

(2010) Nai-Yun Hsu et al.   CELL

Japanese Encephalitis: New Options for Active Immunization

(2010) Scott B. Halstead et al.   CLINICAL INFECTIOUS DISEASES

Japanese encephalitis: update on vaccines and vaccine recommendations

(2010) A Wilder-Smith et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Co-expression of Japanese encephalitis virus prM–E–NS1 antigen with granulocyte-macrophage colony-stimulating factor enhances humoral and anti-virus immunity after DNA vaccination

(2010) Na Gao et al.   IMMUNOLOGY LETTERS

An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses

(2010) M. Lobigs et al.   JOURNAL OF GENERAL VIROLOGY

In Vitro Reconstitution Reveals Key Intermediate States of Trimer Formation by the Dengue Virus Membrane Fusion Protein

(2010) M. Liao et al.   JOURNAL OF VIROLOGY

The Endoplasmic Reticulum Provides the Membrane Platform for Biogenesis of the Flavivirus Replication Complex

(2010) Leah K. Gillespie et al.   JOURNAL OF VIROLOGY

Influence of pr-M Cleavage on the Heterogeneity of Extracellular Dengue Virus Particles

(2010) J. Junjhon et al.   JOURNAL OF VIROLOGY

Safety and Immunogenicity of a Single Administration of Live-attenuated Japanese Encephalitis Vaccine in Previously Primed 2- to 5-year-olds and Naive 12- to 24-month-olds

(2010) Kulkanya Chokephaibulkit et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Overview: Japanese encephalitis

(2010) Usha Kant Misra et al.   PROGRESS IN NEUROBIOLOGY

Immunogenicity of an inactivated Japanese encephalitis vaccine (JE-VAX) in humans over 20 years at USAMRIID: Using PRNT50 as an endpoint for immunogenicity

(2010) Ronald B. Reisler et al.   VACCINE

Adverse event reports following Japanese encephalitis vaccination in the United States, 1999–2009

(2010) Nicole P. Lindsey et al.   VACCINE

Safety analysis of a Vero-cell culture derived Japanese encephalitis vaccine, IXIARO® (IC51), in 6 months of follow-up

(2010) Katrin Dubischar-Kastner et al.   VACCINE

Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO®, IC51

(2010) Katrin Dubischar-Kastner et al.   VACCINE

Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials

(2010) Joseph Torresi et al.   VACCINE

Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities

(2010) Yongxin Yu   VACCINE

Molecular epidemiology of Japanese encephalitis virus circulating in South Korea, 1983-2005

(2010) Seok-Min Yun et al.   Virology Journal

New Vaccines for Japanese Encephalitis

(2010) Scott B. Halstead et al.   Current Infectious Disease Reports

Present and future arboviral threats

(2009) Scott C. Weaver et al.   ANTIVIRAL RESEARCH

Composition and Three-Dimensional Architecture of the Dengue Virus Replication and Assembly Sites

(2009) Sonja Welsch et al.   Cell Host & Microbe

Japanese Encephalitis Vaccine (Inactivated, Adsorbed) [IXIARO®]

(2009) Sean T. Duggan et al.   DRUGS

IC51 Japanese Encephalitis vaccine

(2009) Herwig Kollaritsch et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Ixiaro®: a new vaccine against Japanese encephalitis

(2009) Tomas Jelinek   Expert Review of Vaccines

Focus on flaviviruses: current and future drug targets

(2009) Brian J Geiss et al.   Future Medicinal Chemistry

Genetic characterization of early isolates of Japanese encephalitis virus: genotype II has been circulating since at least 1951

(2009) A. J. Schuh et al.   JOURNAL OF GENERAL VIROLOGY

Japanese encephalitis virus produces a CD4+ Th2 response and associated immunoprotection in an adoptive-transfer murine model

(2009) S. M. Biswas et al.   JOURNAL OF GENERAL VIROLOGY

Mechanisms of Evasion of the Type I Interferon Antiviral Response by Flaviviruses

(2009) Michael S. Diamond   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Japanese Encephalitis: Defining Risk Incidence for Travelers to Endemic Countries and Vaccine Prescribing From the UK and Switzerland: Table 1

(2009) Christoph Hatz et al.   JOURNAL OF TRAVEL MEDICINE

Japanese Encephalitis in Travelers: Review of Cases and Seasonal Risk

(2009) Mads R. Buhl et al.   JOURNAL OF TRAVEL MEDICINE

Virus-Specific Cytolytic Antibodies to Nonstructural Protein 1 of Japanese Encephalitis Virus Effect Reduction of Virus Output from Infected Cells

(2009) V. D. Krishna et al.   JOURNAL OF VIROLOGY

Association of the pr Peptides with Dengue Virus at Acidic pH Blocks Membrane Fusion

(2009) I.-M. Yu et al.   JOURNAL OF VIROLOGY

NS1' of Flaviviruses in the Japanese Encephalitis Virus Serogroup Is a Product of Ribosomal Frameshifting and Plays a Role in Viral Neuroinvasiveness

(2009) E. B. Melian et al.   JOURNAL OF VIROLOGY

3' cis-Acting Elements That Contribute to the Competence and Efficiency of Japanese Encephalitis Virus Genome Replication: Functional Importance of Sequence Duplications, Deletions, and Substitutions

(2009) S.-I. Yun et al.   JOURNAL OF VIROLOGY

Crystal Structure of Dengue Virus Type 1 Envelope Protein in the Postfusion Conformation and Its Implications for Membrane Fusion

(2009) V. Nayak et al.   JOURNAL OF VIROLOGY

The flavivirus NS5 protein is a true RNA guanylyltransferase that catalyzes a two-step reaction to form the RNA cap structure

(2009) M. Issur et al.   RNA

Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: A randomized, observer-blind, controlled Phase 3 study

(2009) Elisabeth Schuller et al.   VACCINE

Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX®1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study

(2009) A. Kaltenböck et al.   VACCINE

Bacterially expressed recombinant envelope protein domain III of Japanese encephalitis virus (rJEV-DIII) elicits Th1 type of immune response in BALB/c mice

(2009) Shailendra Kumar Verma et al.   VACCINE

Immunogenicity and safety of IXIARO® (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age

(2009) A. Kaltenböck et al.   VACCINE

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses

(2009) Bruno Guy et al.   VACCINE

A conserved predicted pseudoknot in the NS2A-encoding sequence of West Nile and Japanese encephalitis flaviviruses suggests NS1' may derive from ribosomal frameshifting

(2009) Andrew E Firth et al.   Virology Journal

Ecology and Geographical Expansion of Japanese Encephalitis Virus

(2008) Andrew F. van den Hurk et al.   Annual Review of Entomology

Molecular targets for flavivirus drug discovery

(2008) Aruna Sampath et al.   ANTIVIRAL RESEARCH

Japanese encephalitis vaccine in travelers

(2008) Tomas Jelinek   Expert Review of Vaccines

Tick-borne flaviviruses: dissecting host immune responses and virus countermeasures

(2008) Shelly J. Robertson et al.   IMMUNOLOGIC RESEARCH

Post-vaccination encephalomyelitis: Literature review and illustrative case

(2008) William Huynh et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Functional entry of dengue virus into Aedes albopictus mosquito cells is dependent on clathrin-mediated endocytosis

(2008) E. G. Acosta et al.   JOURNAL OF GENERAL VIROLOGY

Randomized, Double‐Blind, Placebo‐Controlled Phase 3 Trial of the Safety and Tolerability of IC51, an Inactivated Japanese Encephalitis Vaccine

(2008) E. Tauber et al.   JOURNAL OF INFECTIOUS DISEASES

A Single N-Linked Glycosylation Site in the Japanese Encephalitis Virus prM Protein Is Critical for Cell Type-Specific prM Protein Biogenesis, Virus Particle Release, and Pathogenicity in Mice

(2008) J.-M. Kim et al.   JOURNAL OF VIROLOGY

Humanized Monoclonal Antibodies Derived from Chimpanzee Fabs Protect against Japanese Encephalitis Virus In Vitro and In Vivo

(2008) A. P. Goncalvez et al.   JOURNAL OF VIROLOGY

Yellow Fever Virus NS3 Plays an Essential Role in Virus Assembly Independent of Its Known Enzymatic Functions

(2008) C. G. Patkar et al.   JOURNAL OF VIROLOGY

Role of Nonstructural Protein NS2A in Flavivirus Assembly

(2008) J. Y. Leung et al.   JOURNAL OF VIROLOGY

Viral membrane fusion

(2008) Stephen C Harrison   NATURE STRUCTURAL & MOLECULAR BIOLOGY

A complex RNA motif defined by three discontinuous 5-nucleotide-long strands is essential for Flavivirus RNA replication

(2008) B.-H. Song et al.   RNA

The Flavivirus Precursor Membrane-Envelope Protein Complex: Structure and Maturation

(2008) L. Li et al.   SCIENCE

Structure of the Immature Dengue Virus at Low pH Primes Proteolytic Maturation

(2008) I-M. Yu et al.   SCIENCE

A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: Immunogenicity and anamnestic responses

(2008) Young Mo Sohn et al.   VACCINE

Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51

(2008) E. Schuller et al.   VACCINE

Immune responses of recombinant adenoviruses expressing immunodominant epitopes against Japanese encephalitis virus

(2008) Peng Li et al.   VACCINE

Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51

(2008) Elisabeth Schuller et al.   VACCINE

Endocytic pathway followed by dengue virus to infect the mosquito cell line C6/36 HT

(2008) Clemente Mosso et al.   VIROLOGY

Genome cyclization as strategy for flavivirus RNA replication

(2008) Sergio M. Villordo et al.   VIRUS RESEARCH

Dissecting the Cell Entry Pathway of Dengue Virus by Single-Particle Tracking in Living Cells

(2008) Hilde M. van der Schaar et al.   PLoS Pathogens

Effect of genomic variation in the challenge virus on the neutralization titres of recipients of inactivated JE vaccines – Report of a collaborative study on PRNT50 assays for Japanese encephalitis virus (JE) antibodies

(2007) Morag Ferguson et al.   BIOLOGICALS